CONMED Corporation (CNMD)
NYSE: CNMD · Real-Time Price · USD
40.52
-0.08 (-0.20%)
At close: Jan 2, 2026, 4:00 PM EST
40.52
0.00 (0.00%)
After-hours: Jan 2, 2026, 7:00 PM EST
CONMED Revenue
CONMED had revenue of $337.93M in the quarter ending September 30, 2025, with 6.70% growth. This brings the company's revenue in the last twelve months to $1.35B, up 4.61% year-over-year. In the year 2024, CONMED had annual revenue of $1.31B with 5.00% growth.
Revenue (ttm)
$1.35B
Revenue Growth
+4.61%
P/S Ratio
0.93
Revenue / Employee
$345,505
Employees
3,900
Market Cap
1.25B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.31B | 62.27M | 5.00% |
| Dec 31, 2023 | 1.24B | 199.27M | 19.06% |
| Dec 31, 2022 | 1.05B | 34.84M | 3.45% |
| Dec 31, 2021 | 1.01B | 148.18M | 17.18% |
| Dec 31, 2020 | 862.46M | -92.64M | -9.70% |
| Dec 31, 2019 | 955.10M | 95.46M | 11.11% |
| Dec 31, 2018 | 859.63M | 63.24M | 7.94% |
| Dec 31, 2017 | 796.39M | 32.87M | 4.31% |
| Dec 31, 2016 | 763.52M | 44.35M | 6.17% |
| Dec 31, 2015 | 719.17M | -20.89M | -2.82% |
| Dec 31, 2014 | 740.06M | -22.65M | -2.97% |
| Dec 31, 2013 | 762.70M | -4.44M | -0.58% |
| Dec 31, 2012 | 767.14M | 42.06M | 5.80% |
| Dec 31, 2011 | 725.08M | 11.35M | 1.59% |
| Dec 31, 2010 | 713.72M | 18.98M | 2.73% |
| Dec 31, 2009 | 694.74M | -47.44M | -6.39% |
| Dec 31, 2008 | 742.18M | 47.90M | 6.90% |
| Dec 31, 2007 | 694.29M | 47.48M | 7.34% |
| Dec 31, 2006 | 646.81M | 29.51M | 4.78% |
| Dec 31, 2005 | 617.31M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
CNMD News
- 4 weeks ago - CONMED Corporation Announces Strategic Exit from Gastroenterology Product Lines - Business Wire
- 2 months ago - CONMED Corporation (CNMD) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - CONMED Corporation Announces Third Quarter 2025 Financial Results - Business Wire
- 3 months ago - CONMED Corporation to Announce Third Quarter 2025 Financial Results on November 5, 2025 - Business Wire
- 4 months ago - CONMED Corporation Adds Kim Kelderman to its Board of Directors - Business Wire
- 5 months ago - CONMED Corporation Announces Quarterly Cash Dividend - Business Wire
- 5 months ago - CONMED Corporation (CNMD) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 months ago - CONMED Corporation Announces Second Quarter 2025 Financial Results - Business Wire